Kathy Fiekert

Senior TB Consultant

Kathy Fiekert holds a Master of Science in the Control of Infectious Diseases from the London School of Hygiene and Tropical Medicine, and has over 30 years of experience in public health, infectious disease control programmes and operational research in developing countries.

As a Senior TB Consultant, Kathy has significant experience advising national and local government bodies, NGOs and the donor sector.  Kathy’s work links community engagement, people-centred approaches, ethics, and human rights to strengthen resilient and sustainable systems for health and joint strategic planning, and design innovative approaches to TB care utilising digital health technologies.

Kathy has published extensively and currently serves on several global policy advisory bodies, including the co-chair of CDC Foundation TB Data Optimisation Project Steering Committee and as a member of the TB Modelling and Analysis Consortium Steering Committee.

Within KNCV, Kathy coordinates the People-Centred Framework for TB Programming Approach, and Stigma Reduction & Social Protection Initiatives. Kathy also provides technical support to country and NGO TB programmes on situation and gap analyses, programme design and evaluation, strategic planning, resilient and sustainable systems for health, and management capacity development.

Recent publications

  1. van Oosterhout, D., C. Negri, A. Bedru, Fiekert, I. Leimane and S. Boorsboom (2019). Targeted interventions to improve TB services while addressing stigma related issues, Ethiopia. The Hague KNCV Tuberculosis Foundation/ Challenge TB.
  2. Denholm, J. T., J. C. Millan-Marcelo and Fiekert (2020). “Latent tuberculosis infection and the EndTB Strategy: ethical tensions and imperatives.” The International Journal of Tuberculosis and Lung Disease 24(5): 21-26.
  3. Spruijt, I., D. T. Haile, S. van den Hof, Fiekert, N. Jansen, D. Jerene, E. Klinkenberg, I. Leimane and J. Suurmond (2020). “Knowledge, attitudes, beliefs, and stigma related to latent tuberculosis infection: a qualitative study among Eritreans in the Netherlands.” BMC Public Health 20(1).
  4. Gronholm, P. C., M. Nose, W. H. van Brakel, J. Eaton, B. Ebenso, Fiekert, F. Hanna, M. Milenova, C. Sunkel, C. Barbui and G. Thornicroft (2021). “Reducing stigma and discrimination associated with COVID-19: early-stage pandemic rapid review and practical recommendations.” Epidemiology and Psychiatric Sciences 30(E15).25.
  5. McQuaid, C. F., A. Vassall, T. Cohen, FiekertCOVID/TB Modelling Working Group and R. G. White (2021). “The impact of COVID-19 on TB: a review of the data.” International Journal of TB and Lung Diseases 25(6): 436-446.


read all the KNCV publications

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us


De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.